Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Randomized-controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness.

Preti A, Cella M.

Schizophr Res. 2010 Oct;123(1):30-6. doi: 10.1016/j.schres.2010.07.026. Epub 2010 Aug 21.

PMID:
20727717
2.

Early intervention for psychosis.

Marshall M, Rathbone J.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD004718. Review. Update in: Cochrane Database Syst Rev. 2011;(6):CD004718.

PMID:
17054213
3.

Early intervention for psychosis.

Marshall M, Rathbone J.

Cochrane Database Syst Rev. 2011 Jun 15;(6):CD004718. doi: 10.1002/14651858.CD004718.pub3. Review.

4.

Benzodiazepines alone or in combination with antipsychotic drugs for acute psychosis.

Gillies D, Beck A, McCloud A, Rathbone J, Gillies D.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD003079. Review. Update in: Cochrane Database Syst Rev. 2013;4:CD003079.

PMID:
16235313
5.

Early Intervention for psychosis.

Marshall M, Lockwood A.

Cochrane Database Syst Rev. 2004;(2):CD004718. Review. Update in: Cochrane Database Syst Rev. 2006;(4):CD004718.

PMID:
15106257
6.

Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis.

Smesny S, Milleit B, Hipler UC, Milleit C, Schäfer MR, Klier CM, Holub M, Holzer I, Berger GE, Otto M, Nenadic I, Berk M, McGorry PD, Sauer H, Amminger GP.

Mol Psychiatry. 2014 Mar;19(3):317-24. doi: 10.1038/mp.2013.7. Epub 2013 Mar 12.

PMID:
23478748
7.

Benzodiazepines for schizophrenia.

Dold M, Li C, Tardy M, Khorsand V, Gillies D, Leucht S.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD006391. doi: 10.1002/14651858.CD006391.pub2. Review.

PMID:
23152236
8.

Is clinical intervention in the ultra high risk phase effective?

McGuire P, Selvaraj S, Howes O.

Rev Bras Psiquiatr. 2011 Oct;33 Suppl 2:s161-74. Review. English, Portuguese.

9.

Interventions for psychotic symptoms concomitant with epilepsy.

Farooq S, Sherin A.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD006118. doi: 10.1002/14651858.CD006118.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;12:CD006118.

PMID:
18843704
10.

Antipsychotic interventions in prodromal psychosis: safety issues.

Liu CC, Demjaha A.

CNS Drugs. 2013 Mar;27(3):197-205. doi: 10.1007/s40263-013-0046-1. Review.

PMID:
23436256
11.

Intervention in individuals at ultra-high risk for psychosis: a review and future directions.

McGorry PD, Nelson B, Amminger GP, Bechdolf A, Francey SM, Berger G, Riecher-Rössler A, Klosterkötter J, Ruhrmann S, Schultze-Lutter F, Nordentoft M, Hickie I, McGuire P, Berk M, Chen EY, Keshavan MS, Yung AR.

J Clin Psychiatry. 2009 Sep;70(9):1206-12. doi: 10.4088/JCP.08r04472. Epub 2009 Jun 30. Review.

PMID:
19573499
12.

Preventing a first episode of psychosis: meta-analysis of randomized controlled prevention trials of 12 month and longer-term follow-ups.

van der Gaag M, Smit F, Bechdolf A, French P, Linszen DH, Yung AR, McGorry P, Cuijpers P.

Schizophr Res. 2013 Sep;149(1-3):56-62. doi: 10.1016/j.schres.2013.07.004. Epub 2013 Jul 18.

PMID:
23870806
13.

NEURAPRO-E study protocol: a multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders.

Markulev C, McGorry PD, Nelson B, Yuen HP, Schaefer M, Yung AR, Thompson A, Berger G, Mossaheb N, Schlögelhofer M, Smesny S, de Haan L, Riecher-Rössler A, Nordentoft M, Chen EY, Verma S, Hickie I, Amminger GP.

Early Interv Psychiatry. 2015 Aug 16. doi: 10.1111/eip.12260. [Epub ahead of print]

PMID:
26279065
14.

Early interventions to prevent psychosis: systematic review and meta-analysis.

Stafford MR, Jackson H, Mayo-Wilson E, Morrison AP, Kendall T.

BMJ. 2013 Jan 18;346:f185. doi: 10.1136/bmj.f185. Review. Erratum in: BMJ. 2013;346:f762.

15.

Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.

Marshall M, Crowther R, Almaraz-Serrano A, Creed F, Sledge W, Kluiter H, Roberts C, Hill E, Wiersma D, Bond GR, Huxley P, Tyrer P.

Health Technol Assess. 2001;5(21):1-75. Review.

16.

Olanzapine for schizophrenia.

Duggan L, Fenton M, Rathbone J, Dardennes R, El-Dosoky A, Indran S.

Cochrane Database Syst Rev. 2005 Apr 18;(2):CD001359. Review.

PMID:
15846619
17.

Frontal delta power associated with negative symptoms in ultra-high risk individuals who transitioned to psychosis.

Lavoie S, Schäfer MR, Whitford TJ, Benninger F, Feucht M, Klier CM, Yuen HP, Pantelis C, McGorry PD, Amminger GP.

Schizophr Res. 2012 Jul;138(2-3):206-11. doi: 10.1016/j.schres.2012.03.033. Epub 2012 Apr 19.

PMID:
22520856
18.

Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation).

Powney MJ, Adams CE, Jones H.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD009377. doi: 10.1002/14651858.CD009377.pub2. Review.

PMID:
23152276
19.

Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention.

Francey SM, Nelson B, Thompson A, Parker AG, Kerr M, Macneil C, Fraser R, Hughes F, Crisp K, Harrigan S, Wood SJ, Berk M, McGorry PD.

Schizophr Res. 2010 Jun;119(1-3):1-10. doi: 10.1016/j.schres.2010.02.1071. Epub 2010 Mar 26. Review.

PMID:
20347270
20.

Early psychotic experiences: Interventions, problems and perspectives.

Dimitrakopoulos S, Kollias C, Stefanis NC, Kontaxakis V.

Psychiatriki. 2015 Jan-Mar;26(1):45-54.

PMID:
25880383
Items per page

Supplemental Content

Write to the Help Desk